Kaohsiung, Taiwan

Kuei-Tang Lin

This inventor holds 1 USPTO granted patent. Top assignee: Kaohsiung Medical University. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kuei-Tang Lin. Retrieved from https://idiyas.com/inventor/kuei-tang-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kuei-Tang Lin in Nanotechnology

Introduction: Kuei-Tang Lin is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of nanotechnology, particularly in the development of targeted drug delivery systems. His innovative work focuses on creating nanoparticles that can enhance medical imaging and treatment.

Latest Patents: Kuei-Tang Lin holds a patent for "Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol)." This invention provides a synthetic method for producing superparamagnetic iron oxide nanoparticles that can specifically target folic acid receptors on cell membranes. These nanoparticles exhibit high relaxivity and can be utilized as contrast agents for magnetic resonance imaging (MRI).

Career Highlights: Lin is affiliated with Kaohsiung Medical University, where he conducts research and develops new technologies in the field of medical applications. His work has garnered attention for its potential to improve diagnostic imaging and therapeutic strategies.

Collaborations: Kuei-Tang Lin collaborates with notable colleagues, including Yun-Ming Wang and Ting-Jung Chen, who contribute to his research endeavors. Their combined expertise enhances the impact of their innovations in the medical field.

Conclusion: Kuei-Tang Lin's contributions to nanotechnology and medical imaging exemplify the importance of innovation in healthcare. His patented work on folate-receptor-targeting nanoparticles represents a significant advancement in the field, promising improved diagnostic and therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…